Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Editor

Personal info

View

About

Terms

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Roland Kaufmann

Experimental Transplantation Surgery

Department of General

Visceral and Vascular Surgery

Medical Faculty at the Friedrich Schiller University Jena

Germany

[email]@med.uni-jena.de

Name/email consistency: high

[Claim this account]

Affiliation

Experimental Transplantation Surgery, Department of General, Visceral and Vascular Surgery, Medical Faculty at the Friedrich Schiller University Jena, Germany. 2002 - 2012

References

Proteinase-activated receptor 2 (PAR(2)) in cholangiocarcinoma (CCA) cells: effects on signaling and cellular level. Kaufmann, R., Hascher, A., Mußbach, F., Henklein, P., Katenkamp, K., Westermann, M., Settmacher, U. Histochem. Cell Biol. (2012) [Pubmed]
Proteinase-activated receptor 2-mediated calcium signaling in hepatocellular carcinoma cells. Kaufmann, R., Mussbach, F., Henklein, P., Settmacher, U. J. Cancer Res. Clin. Oncol. (2011) [Pubmed]
Green tea polyphenol epigallocatechin-3-gallate inhibits thrombin-induced hepatocellular carcinoma cell invasion and p42/p44-MAPKinase activation. Kaufmann, R., Henklein, P., Henklein, P., Settmacher, U. Oncol. Rep. (2009) [Pubmed]
Met receptor tyrosine kinase transactivation is involved in proteinase-activated receptor-2-mediated hepatocellular carcinoma cell invasion. Kaufmann, R., Oettel, C., Horn, A., Halbhuber, K.J., Eitner, A., Krieg, R., Katenkamp, K., Henklein, P., Westermann, M., Böhmer, F.D., Ramachandran, R., Saifeddine, M., Hollenberg, M.D., Settmacher, U. Carcinogenesis (2009) [Pubmed]
Thrombin-mediated hepatocellular carcinoma cell migration: cooperative action via proteinase-activated receptors 1 and 4. Kaufmann, R., Rahn, S., Pollrich, K., Hertel, J., Dittmar, Y., Hommann, M., Henklein, P., Biskup, C., Westermann, M., Hollenberg, M.D., Settmacher, U. J. Cell. Physiol. (2007) [Pubmed]
Proteinase-activated receptors (PARs)--the PAR3 Neo-N-terminal peptide TFRGAP interacts with PAR1. Kaufmann, R., Schulze, B., Krause, G., Mayr, L.M., Settmacher, U., Henklein, P. Regul. Pept. (2005) [Pubmed]
Meizothrombin, an intermediate of prothrombin cleavage potently activates renal carcinoma cells by interaction with PAR-type thrombin receptors. Kaufmann, R., Junker, U., Schilli-Westermann, M., Klötzer, C., Scheele, J., Junker, K. Oncol. Rep. (2003) [Pubmed]
PAR-1- and PAR-3-type thrombin receptor expression in primary cultures of human renal cell carcinoma cells. Kaufmann, R., Junker, U., Nuske, K., Westermann, M., Henklein, P., Scheele, J., Junker, K. Int. J. Oncol. (2002) [Pubmed]
The serine proteinase thrombin promotes migration of human renal carcinoma cells by a PKA-dependent mechanism. Kaufmann, R., Junker, U., Junker, K., Nuske, K., Ranke, C., Zieger, M., Scheele, J. Cancer Lett. (2002) [Pubmed]

The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.